Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 8:14 pm Purchase | 2025-12-18 | 13D | KALARIS THERAPEUTICS INC KLRS | Samsara BioCapital, L.P. | 12,954,081 56.500% | 500 (+0.00%) | Filing History |
| 2026-02-17 08:37 am Purchase | 2025-12-31 | 13G | KALARIS THERAPEUTICS INC KLRS | RTW Investments, LP | 1,300,000 5.700% | 1,300,000 (New Position) | Filing History |
| 2025-12-22 4:17 pm Purchase | 2025-12-22 | 13D | KALARIS THERAPEUTICS INC KLRS | Samsara BioCapital, L.P. | 12,953,581 56.500% | 1,505,500 (+13.15%) | Filing History |
| 2025-07-29 1:21 pm Sale | 2025-06-30 | 13G | KALARIS THERAPEUTICS INC KLRS | Invus Public Equities, L.P. | 282,586 1.500% | -4,247 (-1.48%) | Filing History |
| 2025-05-15 2:06 pm Sale | 2025-03-31 | 13G | KALARIS THERAPEUTICS INC KLRS | EcoR1 Capital, LLC | 201,718 1.100% | -206,970 (-50.64%) | Filing History |
| 2025-03-25 7:40 pm Purchase | 2025-03-18 | 13D | KALARIS THERAPEUTICS INC KLRS | Samsara BioCapital, L.P. | 11,448,081 61.200% | 11,448,081 (New Position) | Filing History |
| 2025-03-20 4:32 pm Unchanged | 2025-03-18 | 13G | KALARIS THERAPEUTICS INC KLRS | GILEAD SCIENCES INC. GILD | 723,273 3.900% | 0 (Unchanged) | Filing History |
| 2025-02-14 1:17 pm Sale | 2024-12-31 | 13G | ALLOVIR INC ALVR | EcoR1 Capital, LLC | 408,688 8.100% | -54,589 (-11.78%) | Filing History |
| 2024-10-11 4:02 pm Purchase | 2024-09-30 | 13G | ALLOVIR INC ALVR | Octagon Capital Advisors LP | 487,043 9.700% | 487,043 (New Position) | Filing History |
| 2024-08-02 6:25 pm Purchase | 2024-07-25 | 13G | ALLOVIR INC ALVR | Invus Public Equities, L.P. | 286,833 5.700% | 286,833 (New Position) | Filing History |
| 2024-02-13 4:54 pm Purchase | 2023-12-31 | 13G | ALLOVIR INC ALVR | GILEAD SCIENCES INC. GILD | 723,273 14.600% | 127,429 (+21.39%) | Filing History |
| 2024-02-09 5:12 pm Purchase | 2023-12-31 | 13G | ALLOVIR INC ALVR | Artal International S.C.A. | 286,833 5.800% | 44,347 (+18.29%) | Filing History |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | ALLOVIR INC ALVR | FMR LLC | 247,512 4.990% | -58,852 (-19.21%) | Filing History |
| 2024-02-01 5:11 pm Purchase | 2024-01-22 | 13G | ALLOVIR INC ALVR | EcoR1 Capital, LLC | 463,277 9.300% | 463,277 (New Position) | Filing History |
| 2024-01-09 12:32 pm Sale | 2020-12-16 | 13G | ALLOVIR INC ALVR | John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017 | 232,864 4.690% | -9,004 (-3.72%) | Filing History |
| 2024-01-09 12:29 pm Purchase | 2020-07-29 | 13G | ALLOVIR INC ALVR | John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017 | 241,868 8.980% | 241,868 (New Position) | Filing History |
| 2023-02-09 08:23 am Sale | 2023-02-09 | 13G | ALLOVIR INC ALVR | FMR LLC | 306,364 7.563% | -14,552 (-4.53%) | Filing History |
| 2022-08-05 5:52 pm Purchase | 2022-07-28 | 13G | ALLOVIR INC ALVR | GILEAD SCIENCES INC. GILD | 595,844 14.800% | 595,844 (New Position) | Filing History |
| 2022-08-05 4:31 pm Purchase | 2022-07-28 | 13G | ALLOVIR INC ALVR | Artal International S.C.A. | 242,486 6.000% | 242,486 (New Position) | Filing History |
| 2022-08-05 4:17 pm Purchase | 2022-07-28 | 13D | ALLOVIR INC ALVR | Globeways Holdings II Ltd | 1,155,568 28.600% | 355,151 (+44.37%) | Filing History |